INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,187 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
TA
Thompson Travis AlvinCHIEF ACCOUNTING OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Grant or award
A—
75.0K sh
Jan 2, 2026Jan 6, 2026
Page 1576 of 1855
← PrevNext →
traded Jan 2, 2026
+4d
SEC Form 4

Evidence

9
KR
Krawczyk Joseph R IISR. VP, WW CLIENT ENGAGEMENT
MCHPMICROCHIP TECHNOLOGY INC
Grant or award
A—
122 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
CJ
Carlson Anthony JDirector, President and CEO
ADARRAY DIGITAL INFRASTRUCTURE, INC.
Option exercise
M—
5,022 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
SE
Sparks Paul EugeneDirector
BWINBaldwin Insurance Group, Inc.
Grant or award
A—
982.6K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
AJ
Arntzen Christopher JSVP, GC & Secretary
CABOCable One, Inc.
Grant or award
A—
7,488 sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

9
GP
Gravier PierreCHIEF FINANCIAL OFFICER
PTCTPTC THERAPEUTICS, INC.
Grant or award
A—
50.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
SJ
Sanders Reginald J.Director
EYPTEyePoint, Inc.
Grant or award
A—
40.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
RP
Rayphole Robert P.VP CAO & Controller
APAAPA Corp
Option exercise
M—
720 sh
Jan 4, 2026Jan 6, 2026
traded Jan 4, 2026
+2dSEC Form 4

Evidence

9
DS
Duty StuartDirector
EYPTEyePoint, Inc.
Grant or award
A—
40.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
RJ
Roberts Malcolm JamesEVP & Chief Commercial Officer
BTUPEABODY ENERGY CORP
Tax withholding
F$12K
381 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

9
BS
Bowman Erica SVICE PRESIDENT
EIXEDISON INTERNATIONAL
Disposition to issuer
D$4.19
0 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

8
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$33K
161 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

8
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
177 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

8
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$10K
52 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

8
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
86 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

7
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$381K
1,659 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

7
LM
Lin MarkEVP and CFO
SMTCSEMTECH CORP
Option exercise · 10b5-1 plan
M—
3,164 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

7
SV
Singh VikasEVP & Chief Financial Officer
HCSGHEALTHCARE SERVICES GROUP INC
Option exercise · 10b5-1 plan
M—
3,980 sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

7
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$295K
1,292 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

6
LM
Lin MarkEVP and CFO
SMTCSEMTECH CORP
Tax withholding · 10b5-1 plan
F$88K
1,198 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

6
SN
Sieffert Kristen NPresident
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$18K
750 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

5
KM
Krupka Devin MController, PAO
BANDBandwidth Inc.
Option exercise
M—
352 sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

5
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Grant or award
A—
103.1K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

5
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise
M—
19.7K sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

5
OS
Olsson ShawnChief Commercial Officer
LENZLENZ Therapeutics, Inc.
Grant or award
A—
14.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

5
OS
Olsson ShawnChief Commercial Officer
LENZLENZ Therapeutics, Inc.
Grant or award
A—
84.2K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

5
KM
Krupka Devin MController, PAO
BANDBandwidth Inc.
Option exercise
M—
352 sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

5
CC
Cowan ChadChief Scientific Officer
IPSCCentury Therapeutics, Inc.
Tax withholding
F$1,603
1,611 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

5
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Grant or award
A—
85.7K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

5
OT
O'Connor John TerryGeneral Counsel
GSHDGoosehead Insurance, Inc.
Grant or award
A—
15.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

5
KM
Krupka Devin MController, PAO
BANDBandwidth Inc.
Tax withholding
F$1,692
119 sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

5
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Grant or award
A—
171.4K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

3
LM
Lin MarkEVP and CFO
SMTCSEMTECH CORP
Option exercise · 10b5-1 plan
M—
3,164 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

3
SC
Spice Adam C.Chief Financial Officer
RKLBRocket Lab Corp
Option exercise · 10b5-1 plan
M—
731.3K sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

3
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Derivative conversion · 10b5-1 plan
C—
2,409 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

3
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$50K
4,796 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
4,432 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$46K
4,432 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$19K
102 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M—
2,520 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence